0001762917-19-000002.txt : 20190726 0001762917-19-000002.hdr.sgml : 20190726 20190726113639 ACCESSION NUMBER: 0001762917-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190726 DATE AS OF CHANGE: 20190726 EFFECTIVENESS DATE: 20190726 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alloplex Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001762917 IRS NUMBER: 813772816 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-345137 FILM NUMBER: 19976774 BUSINESS ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-272-1214 MAIL ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001762917 Alloplex Biotherapeutics, Inc. 25-K Olympia Avenue Suite 500 Woburn MA MASSACHUSETTS 01801 857-272-1214 DELAWARE Alloplex Biotherapeutics, LLC None Corporation true 2016 Francescopaolo Borriello c/o Alloplex Biotherapeutics, Inc. 25-K Olympia Street, Suite 500 Woburn MA MASSACHUSETTS 01801 Executive Officer Director Biotechnology Decline to Disclose 06b false 2019-07-17 false true false 0 Indefinite 200000 Indefinite false 2 0 0 0 Other than the payment of salaries and other compensation and benefits, no officer, director, manager or promoter will receive any payments from the proceeds of this offering. false Alloplex Biotherapeutics, Inc. /s/ Francescopaolo Borriello Francescopaolo Borriello Chief Executive Officer 2019-07-24